XCUR
Exicure Inc
NASDAQ: XCUR · HEALTHCARE · BIOTECHNOLOGY
$3.36
+1.51% today
Updated 2026-04-30
Market cap
$22.12M
P/E ratio
—
P/S ratio
13.61x
EPS (TTM)
$-0.79
Dividend yield
—
52W range
$3 – $12
Volume
0.0M
Exicure Inc (XCUR) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-12.20M | $-5.05M | $-19.79M | $-19.49M | $1.32M | $-39.27M | $-34.82M | $-35.66M | $-10.36M | $-2.91M | $-8.55M |
| Capital expenditures | $12000.00 | $394000.00 | $926000.00 | $94000.00 | $1.08M | $3.17M | $968000.00 | $10000.00 | $0.00 | $0.00 | $1000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $370000.00 | $682000.00 | $1.46M | $1.81M | $1.84M | $2.18M | $2.94M | $1.37M | $1.35M | $22000.00 | $2000.00 |
| Free cash flow | $-12.21M | $-5.44M | $-20.71M | $-19.58M | $235000.00 | $-42.44M | $-35.79M | $-35.67M | $-10.36M | $-2.91M | $-8.56M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | $-14.00M | — | — | — | — | — |